
Marilyn G. Macasiano
Examiner (ID: 2397, Phone: (571)270-5205 , Office: P/3688 )
| Most Active Art Unit | 3688 |
| Art Unit(s) | 3688, 3622 |
| Total Applications | 654 |
| Issued Applications | 347 |
| Pending Applications | 61 |
| Abandoned Applications | 258 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 651081
[patent_doc_number] => 07112658
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-09-26
[patent_title] => 'Orphanin FQ receptor polypeptides'
[patent_app_type] => utility
[patent_app_number] => 11/011450
[patent_app_country] => US
[patent_app_date] => 2004-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 20
[patent_no_of_words] => 22677
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/112/07112658.pdf
[firstpage_image] =>[orig_patent_app_number] => 11011450
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/011450 | Orphanin FQ receptor polypeptides | Dec 13, 2004 | Issued |
Array
(
[id] => 6939098
[patent_doc_number] => 20050112661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Methods for delivering nucleic acid molecules into cells and assessment thereof'
[patent_app_type] => utility
[patent_app_number] => 10/976394
[patent_app_country] => US
[patent_app_date] => 2004-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17659
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20050112661.pdf
[firstpage_image] =>[orig_patent_app_number] => 10976394
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/976394 | Methods for delivering nucleic acid molecules into cells and assessment thereof | Oct 28, 2004 | Abandoned |
Array
(
[id] => 7045495
[patent_doc_number] => 20050250090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Assay systems and methods for detecting molecules that interact with SK2 channels'
[patent_app_type] => utility
[patent_app_number] => 10/975798
[patent_app_country] => US
[patent_app_date] => 2004-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 24108
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20050250090.pdf
[firstpage_image] =>[orig_patent_app_number] => 10975798
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/975798 | Assay systems and methods for detecting molecules that interact with SK2 channels | Oct 27, 2004 | Abandoned |
Array
(
[id] => 5743785
[patent_doc_number] => 20060089510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-27
[patent_title] => 'Novel compositions of monomers, oligomers and polymers and methods for making the same'
[patent_app_type] => utility
[patent_app_number] => 10/974549
[patent_app_country] => US
[patent_app_date] => 2004-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 11740
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20060089510.pdf
[firstpage_image] =>[orig_patent_app_number] => 10974549
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/974549 | Novel compositions of monomers, oligomers and polymers and methods for making the same | Oct 25, 2004 | Abandoned |
Array
(
[id] => 6913231
[patent_doc_number] => 20050176989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Transition metal-containing catalysts and processes for their preparation and use as oxidation and dehydrogenation catalysts'
[patent_app_type] => utility
[patent_app_number] => 10/919028
[patent_app_country] => US
[patent_app_date] => 2004-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 59206
[patent_no_of_claims] => 70
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20050176989.pdf
[firstpage_image] =>[orig_patent_app_number] => 10919028
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/919028 | Transition metal-containing catalysts and processes for their preparation and use as oxidation and dehydrogenation catalysts | Aug 15, 2004 | Issued |
Array
(
[id] => 5860238
[patent_doc_number] => 20060229464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-12
[patent_title] => 'Stabilized (meth)acryloyloxyalkyl isocyanate a process for stabilization thereof and a process for preparation of the same'
[patent_app_type] => utility
[patent_app_number] => 10/566184
[patent_app_country] => US
[patent_app_date] => 2004-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3942
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20060229464.pdf
[firstpage_image] =>[orig_patent_app_number] => 10566184
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/566184 | Stabilized (meth)acryloyloxyalkyl isocyanate a process for stabilization thereof and a process for preparation of the same | Jul 26, 2004 | Abandoned |
Array
(
[id] => 7111202
[patent_doc_number] => 20050208657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Delivery of functional protein sequences by translocating polypeptides'
[patent_app_type] => utility
[patent_app_number] => 10/865538
[patent_app_country] => US
[patent_app_date] => 2004-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14749
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20050208657.pdf
[firstpage_image] =>[orig_patent_app_number] => 10865538
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/865538 | Delivery of functional protein sequences by translocating polypeptides | Jun 8, 2004 | Abandoned |
Array
(
[id] => 7122427
[patent_doc_number] => 20050014256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-20
[patent_title] => 'Stem cell and dental pulp harvesting method and apparatus'
[patent_app_type] => utility
[patent_app_number] => 10/857643
[patent_app_country] => US
[patent_app_date] => 2004-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 15209
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20050014256.pdf
[firstpage_image] =>[orig_patent_app_number] => 10857643
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/857643 | Stem cell and dental pulp harvesting method and apparatus | May 27, 2004 | Abandoned |
Array
(
[id] => 7050400
[patent_doc_number] => 20050186287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-25
[patent_title] => 'Copper agonist that binds on the copper binding site of APP and/or exerts an inhibiting effect on the release of amyloid Abeta peptide'
[patent_app_type] => utility
[patent_app_number] => 10/848016
[patent_app_country] => US
[patent_app_date] => 2004-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5731
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20050186287.pdf
[firstpage_image] =>[orig_patent_app_number] => 10848016
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/848016 | Copper agonist that binds on the copper binding site of APP and/or exerts an inhibiting effect on the release of amyloid Abeta peptide | May 18, 2004 | Abandoned |
Array
(
[id] => 535116
[patent_doc_number] => 07173010
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-02-06
[patent_title] => 'Orphanin FQ receptor'
[patent_app_type] => utility
[patent_app_number] => 10/848637
[patent_app_country] => US
[patent_app_date] => 2004-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 20
[patent_no_of_words] => 24701
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/173/07173010.pdf
[firstpage_image] =>[orig_patent_app_number] => 10848637
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/848637 | Orphanin FQ receptor | May 18, 2004 | Issued |
Array
(
[id] => 7033585
[patent_doc_number] => 20050032094
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Regulatory DNA sequences of the human catalytic telomerase sub-unit gene, diagnostic and therapeutic use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/840455
[patent_app_country] => US
[patent_app_date] => 2004-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 17069
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20050032094.pdf
[firstpage_image] =>[orig_patent_app_number] => 10840455
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/840455 | Regulatory DNA sequences of the human catalytic telomerase sub-unit gene, diagnostic and therapeutic use thereof | May 5, 2004 | Abandoned |
Array
(
[id] => 7256207
[patent_doc_number] => 20040259828
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Intravascular delivery of non-viral nucleic acid'
[patent_app_type] => new
[patent_app_number] => 10/838622
[patent_app_country] => US
[patent_app_date] => 2004-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 17562
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20040259828.pdf
[firstpage_image] =>[orig_patent_app_number] => 10838622
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/838622 | Intravascular delivery of non-viral nucleic acid | May 3, 2004 | Abandoned |
Array
(
[id] => 7025528
[patent_doc_number] => 20050019922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-27
[patent_title] => 'Site-specific cell perforation technique'
[patent_app_type] => utility
[patent_app_number] => 10/836773
[patent_app_country] => US
[patent_app_date] => 2004-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 11817
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20050019922.pdf
[firstpage_image] =>[orig_patent_app_number] => 10836773
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/836773 | Site-specific cell perforation technique | Apr 29, 2004 | Abandoned |
Array
(
[id] => 6938536
[patent_doc_number] => 20050112099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Tumor antigen BFA5 for prevention and / or treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 10/825026
[patent_app_country] => US
[patent_app_date] => 2004-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13878
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20050112099.pdf
[firstpage_image] =>[orig_patent_app_number] => 10825026
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/825026 | Tumor antigen BFA5 for prevention and / or treatment of cancer | Apr 14, 2004 | Abandoned |
Array
(
[id] => 7025467
[patent_doc_number] => 20050019861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-27
[patent_title] => 'Enzymatically active recombinant glucocerebrosidase'
[patent_app_type] => utility
[patent_app_number] => 10/814025
[patent_app_country] => US
[patent_app_date] => 2004-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7429
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20050019861.pdf
[firstpage_image] =>[orig_patent_app_number] => 10814025
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/814025 | Enzymatically active recombinant glucocerebrosidase | Mar 30, 2004 | Abandoned |
Array
(
[id] => 232997
[patent_doc_number] => 07598424
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-10-06
[patent_title] => 'Process for production of bisphenol A'
[patent_app_type] => utility
[patent_app_number] => 10/542797
[patent_app_country] => US
[patent_app_date] => 2004-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7430
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/598/07598424.pdf
[firstpage_image] =>[orig_patent_app_number] => 10542797
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/542797 | Process for production of bisphenol A | Mar 24, 2004 | Issued |
Array
(
[id] => 6956039
[patent_doc_number] => 20050212409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'Organic luminescent materials'
[patent_app_type] => utility
[patent_app_number] => 10/807130
[patent_app_country] => US
[patent_app_date] => 2004-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 9771
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20050212409.pdf
[firstpage_image] =>[orig_patent_app_number] => 10807130
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/807130 | Organic luminescent materials | Mar 22, 2004 | Abandoned |
Array
(
[id] => 616300
[patent_doc_number] => 07144711
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-12-05
[patent_title] => 'AGS proteins and nucleic acid molecules and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 10/804491
[patent_app_country] => US
[patent_app_date] => 2004-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 41898
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/144/07144711.pdf
[firstpage_image] =>[orig_patent_app_number] => 10804491
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/804491 | AGS proteins and nucleic acid molecules and uses therefor | Mar 18, 2004 | Issued |
Array
(
[id] => 7190149
[patent_doc_number] => 20040204360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-14
[patent_title] => 'Pharmaceutical composition intended for the treatment or for the prevention of diabetes, of cancer or of waardenburg syndrome'
[patent_app_type] => new
[patent_app_number] => 10/802089
[patent_app_country] => US
[patent_app_date] => 2004-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4297
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20040204360.pdf
[firstpage_image] =>[orig_patent_app_number] => 10802089
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/802089 | Pharmaceutical composition intended for the treatment or for the prevention of diabetes, of cancer or of waardenburg syndrome | Mar 15, 2004 | Abandoned |
Array
(
[id] => 7170257
[patent_doc_number] => 20050202561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Plasmids encoding therapeutic agents'
[patent_app_type] => utility
[patent_app_number] => 10/800052
[patent_app_country] => US
[patent_app_date] => 2004-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14512
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20050202561.pdf
[firstpage_image] =>[orig_patent_app_number] => 10800052
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/800052 | Plasmids encoding therapeutic agents | Mar 11, 2004 | Issued |